Login to Your Account



Pharma: Other News To Note


Wednesday, May 29, 2013
• Grunenthal Group, of Aachen, Germany, entered a licensing agreement with Purdue Pharma LP, of Stamford, Conn., regarding certain intellectual property rights for the development of an abuse-deterrent formulation technology for extended-release morphine sulfate.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription